Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis

Published:2008-07 Issue:1 Volume:48 Page:109-118
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Uno Masafumi,Kurita Seiichiro,Misu Hirofumi,Ando Hitoshi,Ota Tsuguhito,Matsuzawa‐Nagata Naoto,Kita Yuki,Nabemoto Satoko,Akahori Hiroshi,Zen Yoh,Nakanuma Yasuni,Kaneko Shuichi,Takamura Toshinari

Publisher

Wiley

Subject

Hepatology

Reference39 articles.

1. Nonalcoholic steatohepatitis;Reid;Gastroenterology,2001

2. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

3. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome;Marchesini;HEPATOLOGY,2003

4. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome;Marchesini;Diabetes,2001

5. Liver pathology and the metabolic syndrome X in severe obesity;Marceau;J Clin Endocrinol Metab,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications;Human Nutrition & Metabolism;2024-09

2. Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy;Life Sciences;2024-08

3. Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit;International Immunopharmacology;2024-08

4. Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications;Biomedicine & Pharmacotherapy;2024-06

5. Diabetes Accelerates Steatohepatitis in Mice;The American Journal of Pathology;2024-05